Roche

November 30, 2022

“We were highly impressed by the technologies, the creativity, the complex solutions, and the passion and commitment of Israeli startups to deal with the challenges posed by Alzheimer’s disease”

Roche is one of the world’s largest biotechnology companies and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. The combined strengths of pharmaceutical and diagnostics under one roof have made Roche the leader in personalised healthcare.

Together with Roche Israel, Start-Up Nation Central held the “Alzheimer’s Innovation Challenge”, in order to discover the Israeli startups that are able to solve one of the most significant challenges facing scientists and physicians researching and treating Alzheimer’s – diagnosing the disease in its early stages. The challenge featured companies that offer solutions for early diagnosis of the disease, statistical surveys that can predict the risk of getting Alzheimer’s, as well as digital means of prevention, monitoring of patients, and elevating their quality of life.

 

Avi Danziger
GM, Roche Israel